Paclitaxel Injection

Form: Injection

Strength: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, 500 mg/83.3 mL

Reference Brands: Taxol(US & EU)

Category: Oncology Cancer Care

Paclitaxel Injection 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, and 500 mg/83.3 mL is a vital chemotherapy drug used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and other cancers. Approved in both the U.S. and EU, Paclitaxel is administered via IV infusion and acts by disrupting microtubule formation, inhibiting cancer cell division. Available in various strengths, it is a cornerstone drug for oncology centers and hospitals. This makes it a key product in oncology B2B distribution, ensuring effective cancer treatment for a wide range of malignancies.